Compare ImmunityBio Inc. Common Stock (IBRX) vs Vanguard Emerging Markets Stock Index Fund ETF (VWO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs Vanguard Emerging Markets Stock Index Fund ETF — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Vanguard Emerging Markets Stock Index Fund ETF trades at $59.23 (market cap $168.50B). The key difference: Vanguard Emerging Markets Stock Index Fund ETF is far larger — about 16.3× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (11,745,198 versus 5,276,564). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Vanguard Emerging Markets Stock Index Fund ETF for 134 Days on average.
| IBRX | VWO | |
|---|---|---|
Market Cap | $10.33B | $168.50B |
Volume | 11,745,198 | 5,276,564 |
Sector | Health | — |
52-Week High | $11.55 | $61.44 |
52-Week Low | $1.98 | $52.42 |
Typical Hold Time | 0 Days | 134 Days |
Enterprise Value | $10.79B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VWO trades at $59.85, down 1.27% with a bearish technical signal. The ETF faces mixed sentiment as AI-driven semiconductor exposure in Taiwan provides strength while China's economic slowdown and property sector weakness create headwinds. Recent institutional buying by Allianz and Alamar Capital contrasts with technical indicators showing bearish moving averages and neutral oscillators.
The emerging markets ETF offers diversification benefits but faces concentration risks in Chinese holdings. While AI infrastructure spending supports Taiwan exposure, China's economic challenges and potential single-stock concentration pose significant risks. The neutral RSI suggests limited momentum, requiring careful monitoring of emerging market economic data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Read more on VWO →
